| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| May 4, 2026 | Hemab Therapeutics Holdings, Inc. (COAG) | C | 27,720 | - | - | View Details Filing |
| May 4, 2026 | Hemab Therapeutics Holdings, Inc. (COAG) | C | 42,341 | - | - | View Details Filing |
| May 4, 2026 | Hemab Therapeutics Holdings, Inc. (COAG) | C | 3,607,846 | - | - | View Details Filing |
| May 4, 2026 | Hemab Therapeutics Holdings, Inc. (COAG) | C | 18,146 | - | - | View Details Filing |
| May 4, 2026 | Hemab Therapeutics Holdings, Inc. (COAG) | C | 56,972 | - | - | View Details Filing |
| May 4, 2026 | Hemab Therapeutics Holdings, Inc. (COAG) | C | 221,188 | - | - | View Details Filing |
| May 4, 2026 | Hemab Therapeutics Holdings, Inc. (COAG) | C | 1,009,052 | - | - | View Details Filing |
| May 4, 2026 | Hemab Therapeutics Holdings, Inc. (COAG) | C | 10,054 | - | - | View Details Filing |
| May 4, 2026 | Hemab Therapeutics Holdings, Inc. (COAG) | P | 2,541,250 | $18.00 | $45,742,500.00 | View Details Filing |
158 more transactions available โ create a free account to see 12 months of history | ||||||